<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Digit. Health</journal-id>
<journal-title>Frontiers in Digital Health</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Digit. Health</abbrev-journal-title>
<issn pub-type="epub">2673-253X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fdgth.2023.1131731</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Digital Health</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Emerging data inputs for infectious diseases surveillance and decision making</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Shausan</surname><given-names>Aminath</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/1944296/overview"/></contrib>
<contrib contrib-type="author"><name><surname>Nazarathy</surname><given-names>Yoni</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author"><name><surname>Dyda</surname><given-names>Amalie</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/1070926/overview" /></contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><addr-line>School of Public Health</addr-line>, <institution>The University of Queensland</institution>, <addr-line>Brisbane, QLD</addr-line>, <country>Australia</country></aff>
<aff id="aff2"><label><sup>2</sup></label><addr-line>School of Mathematics and Physics</addr-line>, <institution>The University of Queensland</institution>, <addr-line>Brisbane</addr-line>, <addr-line>QLD</addr-line>, <country>Australia</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> Enrique Castro-S&#x00E1;nchez, Imperial College London, United Kingdom</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> C. Mahony Re&#x00E1;tegui Rivera, National Institute of Health (Peru), Peru</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Aminath Shausan <email>a.shausan@uq.edu.au</email></corresp>
<fn fn-type="other" id="fn001"><p><bold>Specialty Section:</bold> This article was submitted to Health Technology Implementation, a section of the journal Frontiers in Digital Health</p></fn>
</author-notes>
<pub-date pub-type="epub"><day>04</day><month>04</month><year>2023</year></pub-date>
<pub-date pub-type="collection"><year>2023</year></pub-date>
<volume>5</volume><elocation-id>1131731</elocation-id>
<history>
<date date-type="received"><day>26</day><month>12</month><year>2022</year></date>
<date date-type="accepted"><day>20</day><month>03</month><year>2023</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2023 Shausan, Nazarathy and Dyda.</copyright-statement>
<copyright-year>2023</copyright-year><copyright-holder>Shausan, Nazarathy and Dyda</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Infectious diseases create a significant health and social burden globally and can lead to outbreaks and epidemics. Timely surveillance for infectious diseases is required to inform both short and long term public responses and health policies. Novel data inputs for infectious disease surveillance and public health decision making are emerging, accelerated by the COVID-19 pandemic. These include the use of technology-enabled physiological measurements, crowd sourcing, field experiments, and artificial intelligence (AI). These technologies may provide benefits in relation to improved timeliness and reduced resource requirements in comparison to traditional methods. In this review paper, we describe current and emerging data inputs being used for infectious disease surveillance and summarize key benefits and limitations.</p>
</abstract>
<kwd-group>
<kwd>infectious diseases</kwd>
<kwd>digital surveillance</kwd>
<kwd>emerging data inputs</kwd>
<kwd>field experiments</kwd>
<kwd>artificial intelligence</kwd>
<kwd>crowd sourcing</kwd>
<kwd>physiological measures</kwd>
<kwd>COVID-19</kwd>
</kwd-group>
<contract-num rid="cn001">&#x00A0;</contract-num>
<contract-sponsor id="cn001">University of Queensland&#x2019;s AI<named-content content-type="fundref-id">10.13039/501100001794</named-content></contract-sponsor>
<counts>
<fig-count count="0"/>
<table-count count="1"/><equation-count count="3"/><ref-count count="60"/><page-count count="0"/><word-count count="0"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro"><title>Introduction</title>
<p>Infectious diseases create significant health and social burden globally and can lead to outbreaks and epidemics, highlighted by COVID-19. As of November 29, 2022, there have been almost 638 million confirmed cases and over 6 million deaths of COVID-19 globally.<xref ref-type="fn" rid="FN0001"><sup>1</sup></xref> Prior to this, many other infectious diseases contributed significantly to global mortality and morbidity. Infectious disease threats have arisen in the form of the 2009 Swine Flu pandemic, Middle East respiratory syndrome coronavirus and the West Africa Ebola virus epidemic in West Africa. Cases of newly emerging infectious disease are likely to rise in coming years due to changes in population demographics, climate change, increases in international travel and changes in agriculture, land use, and sanitation (<xref ref-type="bibr" rid="B1">1</xref>).</p>
<p>Timely surveillance of infectious diseases is essential to plan targeted long and short term public health response and prevention efforts. Traditionally, infectious disease data are gathered by public health authorities in the form of positive laboratory tests and hospitalization and death data. Various non-government organizations, such as the World Health Organization (WHO) collect and report these data on a global level.<xref ref-type="fn" rid="FN0001"><sup>1</sup></xref> Additional global reporting for COVID-19 specifically has also been implemented by a number of organizations,<xref ref-type="fn" rid="FN0002"><sup>2</sup></xref> (<xref ref-type="bibr" rid="B2">2</xref>). However, such data requires significant effort from public health officials and may not be consistently collected on a national or regional scale. There can also be delays in reporting and inconsistencies in reporting of deaths and positive cases. Hospitalization and deaths capture primarily severe cases and may not identify those who have mild symptoms or are asymptomatic. Due to these limitations, these data may not provide the true incidence of the disease.</p>
<p>Over recent years, novel data inputs have emerged to complement traditional surveillance of infectious diseases. This includes the use of sensors and mobile apps to collect symptoms and disease data, crowd sourcing data using Internet based surveys and mobile apps, field experiment data based on scenario analysis, as well as social media and web search data in conjunction with artificial intelligence methods to predict disease outbreaks. Surveillance using these types of data inputs may provide benefits over traditional data sources in that they can provide additional timeliness and are often less resource intensive. We aim to provide an overview of different types of novel data inputs for infectious diseases.</p>
<sec id="s1a"><title>Online physiological measures</title>
<p>During the early phase of the pandemic, many governments implemented temperature checks, using classical thermometers, as a surveillance method at specific locations. However, this was limited by a single time point for each individual and may not identify all positive cases (<xref ref-type="bibr" rid="B3">3</xref>). Real-time temperature reading tools such as the smart thermometer and wearable devices have been tested as potential tools for tracking COVID-19. These tools measure physiological matrices of an individual to identify deviations from a baseline level, which may indicate onset of an illness.</p>
<p>Prior to COVID-19, the smart thermometer has been popularly applied in the US for monitoring flu (Influenza) (<xref ref-type="bibr" rid="B4">4</xref>) and personal health risk indicators. During early 2020, data from these thermometers was utilized to forecast COVID-19 hot spots in various US states by correlating anomalously high influenza levels with confirmed COVID-19 cases (<xref ref-type="bibr" rid="B5">5</xref>). Similarly, continuous wearable devices were originally applied to track influenza but have been translated to detect COVID-19 (<xref ref-type="bibr" rid="B6">6</xref>). Data from smartwatches and Fitbit trackers has been applied to detect pre-symptomatic cases of COVID-19 (<xref ref-type="bibr" rid="B7">7</xref>). The WHOOP fitness tracker has been used to identify pre-symptomatic COVID-19 cases by analyzing changes in respiratory rate and heart rate data gathered from users (<xref ref-type="bibr" rid="B8">8</xref>).</p>
<p>Data inputs from wearables combined with additional sources have also shown value in surveillance. Prior to the pandemic, the TempTraq skin patch,<xref ref-type="fn" rid="FN0003"><sup>3</sup></xref> a disposable skin patch with wireless temperature monitoring, was used for diagnosis and early detection of health risks. Data from the skin patch with data from Fitbit smartwatches and bio specimens have been used to assist health care workers to self-monitor COVID-19 (<xref ref-type="bibr" rid="B9">9</xref>). The TemPredict (<xref ref-type="bibr" rid="B10">10</xref>) study investigated whether physiological data such as temperature and heart rate collected by Oura Ring, with self-reported daily symptoms, could predict COVID-19 symptoms. Results showed a correlation between elevated temperature and self-reported fever (<xref ref-type="bibr" rid="B11">11</xref>) and algorithms have been developed to identify onset of (<xref ref-type="bibr" rid="B12">12</xref>) and recovery from COVID-19 (<xref ref-type="bibr" rid="B13">13</xref>). The Corona Data Donation project uses data from wearable devices<xref ref-type="fn" rid="FN0004"><sup>4</sup></xref> with data, such as age and postcode, to provide a daily interactive fever map for COVID-19 hotspots (<xref ref-type="bibr" rid="B14">14</xref>). The Digital Engagement and Tracking for Early Control and Treatment (DETECT) study<xref ref-type="fn" rid="FN0005"><sup>5</sup></xref> involved collection of data from volunteers across the US via a smartwatch or activity tracker with self-reported symptoms and diagnostic test results. By evaluating changes in heart rate, sleep, activity levels, and symptoms, these data can identify cases with greater success than symptoms alone (<xref ref-type="bibr" rid="B15">15</xref>).</p>
</sec>
<sec id="s1b"><title>Crowd sourcing-surveillance</title>
<p>Crowd sourcing involves the collection of information from a large group of people. With the increasing use of the internet these methods are now utilizing digital platforms. For infectious disease surveillance, studies often capture data on self-reported infection via apps or online surveys.</p>
<p>Online surveys for surveillance began in 2003 with the Great Influenza Survey (de Grote Griepmeting) which collects influenza symptoms from participants on a weekly basis. This shows similarity between seasonal influenza measured in the study compared to data reported by general practitioners (<xref ref-type="bibr" rid="B16">16</xref>). Tracking influenza through online surveys expanded quickly, with influenza systems now set up in the US (<xref ref-type="bibr" rid="B17">17</xref>), Portugal (<xref ref-type="bibr" rid="B18">18</xref>), Europe (<xref ref-type="bibr" rid="B16">16</xref>), and Australia (<xref ref-type="bibr" rid="B19">19</xref>). Since COVID-19 emerged, many of these systems have been adapted to include surveillance for COVID-19 (<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>). The CoronaSurveys (<xref ref-type="bibr" rid="B22">22</xref>) and the Global COVID-19 Trends and Impact Survey (<xref ref-type="bibr" rid="B23">23</xref>) provide global and country specific daily incidence rates and risk areas for COVID-19. Both surveys are available in multiple languages, attracting participants globally. These types of data collection have shown to provide more timely outbreak signals than testing, hospitalization, and death counts (<xref ref-type="bibr" rid="B24">24</xref>). Some systems also incorporate an information feedback loop. The Flu Near You (<xref ref-type="bibr" rid="B17">17</xref>) surveillance program tracks influenza symptoms in the US and Canada. Users are able to compare these data with influenza data from the Centers for Disease Control and Prevention sentinel influenza network, and Google Flu Trends. Participants can also identify local sources for influenza vaccination (<xref ref-type="bibr" rid="B17">17</xref>).</p>
<p>Numerous mobile phone apps have also been developed to track COVID-19. The COVID Symptom Study app records user reported symptoms.<xref ref-type="fn" rid="FN0006"><sup>6</sup></xref> This data has been used to track population incidence of COVID-19 and to identify hot spots and regions at high risk for COVID-19 (<xref ref-type="bibr" rid="B25">25</xref>). The data has been also applied to reveal long-lasting and short-term COVID-19 symptoms (<xref ref-type="bibr" rid="B26">26</xref>).</p>
<p>Other studies have focused on monitoring contact patterns and evaluating adherence to social distancing policies. A UK contact tracing survey documented participants age, contact location and level of physical contact (<xref ref-type="bibr" rid="B27">27</xref>). Comparing contact patterns during lockdown and social contacts made during a non-epidemic period showed physical distancing measures substantially reduced contact levels. Citizens in China are required to scan a QR code when accessing public spaces to verify their infection status. The QR code provides individual infection risk, based on locations and medical information(<xref ref-type="bibr" rid="B28">28</xref>). Contact tracing via QR coding system has been implemented in various other locations, such as the UK (<xref ref-type="bibr" rid="B29">29</xref>) and Australia (<xref ref-type="bibr" rid="B30">30</xref>).</p>
<p>Crowd sourcing methods are expanding to collect data for a wider range of diseases. The Mo-Buzz system identifies dengue hot spots in the Colombo, Sri Lanka (<xref ref-type="bibr" rid="B31">31</xref>). Participants provide dengue symptoms and post pictures of potential dengue mosquito&#x2013;breeding sites. The system provides data as visual maps and also recommends educational materials. In Puerto Rico, a similar surveillance program called SaludBoricua monitors a number of acute illnesses including influenza, dengue, and leptospirosis (<xref ref-type="bibr" rid="B32">32</xref>).</p>
</sec>
<sec id="s1c"><title>Novel field experiments</title>
<p>Asymptomatic individuals can also contribute significant risk to the spread of diseases. As discussed previously, various efforts have been made to identify asymptotic individuals via contact tracing. A number of field experiments have also been performed to automatically monitor contact patterns. Data inputs are gathered using applications designed for cellular devices utilizing GPS location tracking.</p>
<p>The UK FluPhone study (<xref ref-type="bibr" rid="B33">33</xref>) investigated how social encounters shape the spread of infectious diseases. Participants reported influenza-like symptoms through the Fluphone app. The app also collects proximity of participants&#x2019; devices through Bluetooth and location via GPS. Participants were informed about an estimate of the number of encounters they made and a real-time visualization of the spread of virtual SEIR type diseases in the contact network (<xref ref-type="bibr" rid="B34">34</xref>). The Safe Blues experiment<xref ref-type="fn" rid="FN0007"><sup>7</sup></xref> is a similar study, which took place at the University of Auckland during 2021&#x2013;2022 (<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>), examining how physical interactions affect the spread of diseases. The Safe Blues Android app spreads multiple safe virtual virus strands via Bluetooth based on individual&#x2019;s physical proximity, with strands mimicking the behavior of biological viruses. Data is presented as a real-time and historic dashboard.</p>
<p>The 2018&#x2013;2019 &#x201C;Contagion! The BBC Four Pandemic&#x201D; experiment (<xref ref-type="bibr" rid="B37">37</xref>) recruited nearly 30,000 volunteers to download the &#x201C;BBC Pandemic app.&#x201D; The app records GPS location during daily activities, and self-reported contacts. Analysis showed that the contact network structure constructed had the potential for understanding and controlling real-world diseases such as the spread of influenza-like viruses (<xref ref-type="bibr" rid="B38">38</xref>). The data was also used to simulate various non-pharmaceutical intervention strategies, such as case isolation and social distancing to investigate their effectiveness on limiting the spread of the disease (<xref ref-type="bibr" rid="B39">39</xref>).</p>
<p>A number of these experiments have been conducted in the context of mass-gatherings. The RESTART-19 experiment conducted in Germany examined the transmission risks of SARS-CoV-2 in indoor mass-gathering events (<xref ref-type="bibr" rid="B40">40</xref>). Using contact tracing devices, participant movements were measured during a concert. This data was incorporated with a computational model of the arena simulating infectious aerosol distribution allowing the development of an individual-based model to estimate the excess burden of the COVID-19 epidemic caused by this event. The study concluded that with moderate hygiene practices and conditions of good ventilation, mass-gathering events contribute little to the spread of COVID-19.</p>
<p>A similar experiment in South Korea recruited healthcare workers involved in two protests (<xref ref-type="bibr" rid="B41">41</xref>) to self-report COVID-19 symptoms via an app. Following the rallies, PCR tests were conducted for 609 of the 646 (<inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IM1"><mml:mn>94</mml:mn><mml:mtext>&#x0025;</mml:mtext></mml:math></inline-formula>) of the attendees, with all tests negative. However, the PCR tests were performed on a sub sample of attendees and may not provide the true incidence rate. An indoor mass-gathering randomized clinical trial in Spain also assessed the risk of COVID-19 transmission during a concert (<xref ref-type="bibr" rid="B42">42</xref>). Contact tracing during the event was performed through a mobile phone app. After eight days, PCR tests showed that less than <inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IM2"><mml:mn>1</mml:mn><mml:mtext>&#x0025;</mml:mtext></mml:math></inline-formula> of participants in the control group had a positive test result and no participant the intervention group tested positive. This provided preliminary evidence on the effectiveness of comprehensive measures to create safe indoor mass-gathering events.</p>
<p>To develop safe practices for mass-gatherings a series of trials called Fieldlab Events were carried out in The Netherlands during February and March 2021.<xref ref-type="fn" rid="FN0008"><sup>8</sup></xref> Four types of experiments investigated the risk of relaxing mask wearing and social distancing measures during mass-gathering events. Contact tracing devices and cameras were used to monitor participants&#x2019; behavior during the events. Seven preventive measures were recommended for gatherings in addition to venues adhering to ventilation regulations for indoor events.</p>
</sec>
<sec id="s1d"><title>Artificial intelligence assisted data sourcing</title>
<p>Combining artificial intelligence (AI) and information available from informal sources is another surveillance method being applied to infectious diseases. These methods allow analysis and interpretation of large datasets sourced from various sources such as online news and media, expert blogs, validated official alerts (e.g., WHO), clinical reports, social media, and airline data. The most common types of AI methods applied include knowledge-based (KB) techniques, natural language processing (NLP), and machine learning (ML). KB techniques use specific keywords and phrases determined by experts to quickly search through various types of information sources. NLP enables machines to process and interpret human language and perform tasks such as translation and disease classification. ML is the process of applying algorithms that allow machines to automatically learn and improve from experience (<xref ref-type="bibr" rid="B43">43</xref>). <xref ref-type="table" rid="T1">Table&#x00A0;1</xref> presents key global systems that incorporate AI methods for public health surveillance and their data sources.</p>
<table-wrap id="T1" position="float"><label>Table 1</label>
<caption><p>Global surveillance systems incorporating artificial intelligence.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">System</th>
<th valign="top" align="left">Type(s) of surveillance</th>
<th valign="top" align="left">AI methods</th>
<th valign="top" align="left">Data sources</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">GPHIN</td>
<td valign="top" align="left">Disease outbreaks, infectious diseases, contaminated food and water bioterrorism and exposure to chemicals, natural disasters, and issues related to the safety of products, drugs and medical devices and radioactive agents</td>
<td valign="top" align="left">KB, ML, NLP</td>
<td valign="top" align="left">Newspapers, online articles, emails, expert blogs, public health bodies and social media</td>
</tr>
<tr>
<td valign="top" align="left">HealthMap</td>
<td valign="top" align="left">Infectious disease outbreaks</td>
<td valign="top" align="left">ML, NLP</td>
<td valign="top" align="left">News media (e.g., Google News), expert-curated accounts (e.g., ProMED Mail), and validated official alerts World Health Organization announcements</td>
</tr>
<tr>
<td valign="top" align="left">BlueDot</td>
<td valign="top" align="left">Infectious disease outbreaks and risk assessments</td>
<td valign="top" align="left">ML, NLP</td>
<td valign="top" align="left">Online articles and airline data</td>
</tr>
<tr>
<td valign="top" align="left">Metabiota</td>
<td valign="top" align="left">Infectious disease outbreaks and risk assessments</td>
<td valign="top" align="left">ML, NLP</td>
<td valign="top" align="left">Data from various communities and regional clinics, online reports, social media data and airline data</td>
</tr>
<tr>
<td valign="top" align="left">WHO-EIOS</td>
<td valign="top" align="left">Outbreaks, risk assessments, pattern discovery and forecasting new outbreaks of all diseases</td>
<td valign="top" align="left">ML, NLP</td>
<td valign="top" align="left">Online media and specific social media sources, government and official web sites, news aggregators, blogs and expert groups, and collaborating initiatives (ProMED, GPHIN, HealthMap and the Europe Media Monitors</td>
</tr>
<tr>
<td valign="top" align="left">BioCaster</td>
<td valign="top" align="left">Infectious disease outbreaks</td>
<td valign="top" align="left">ML, NLP</td>
<td valign="top" align="left">Google News, ProMed Mail, MedISys, WHO, The United Nations, The European Centre for Disease Prevention and Control, Center for Infectious Disease Research and Policy, EurekAlert!, China News Service, The Food and Agriculture Organization of the United Nations</td>
</tr>
<tr>
<td valign="top" align="left">MedISys</td>
<td valign="top" align="left">Monitoring infectious diseases, bioterrorism, and chemical, biological, radiological and nuclear threats</td>
<td valign="top" align="left">KB, NLP, ML</td>
<td valign="top" align="left">Online articles</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The Global Public Health Intelligence Network (GPHIN<xref ref-type="fn" rid="FN0009"><sup>9</sup></xref>) was the first digital tool providing early warnings for diseases worldwide (<xref ref-type="bibr" rid="B44">44</xref>), and provided early detection of SARS in 2002 (<xref ref-type="bibr" rid="B45">45</xref>). The system automatically extracts data from media aggregators such as Google News, other online news, public health organizations and expert blogs, which are analyzed using KB, NLP, and ML methods. These findings are validated and fine tuned by experts and displayed as maps, graphs and listed documents (<xref ref-type="bibr" rid="B45">45</xref>). Initially the system monitored human diseases, however the platform has been expanded to include food safety surveillance.</p>
<p>The HealthMap,<xref ref-type="fn" rid="FN0010"><sup>10</sup></xref> BlueDot<xref ref-type="fn" rid="FN0011"><sup>11</sup></xref> and Metabiota<xref ref-type="fn" rid="FN0012"><sup>12</sup></xref> platforms integrate data from a range of formal and informal sources including news media such as Google News, expert curated accounts such as ProMed-Mail, social media and validated official alerts such as WHO (<xref ref-type="bibr" rid="B46">46</xref>). These systems use NLP and ML to analyse these data for public health use. HealthMap was among the first systems to issue an early warning of COVID-19 outbreak 11 days prior to WHO confirming the disease (<xref ref-type="bibr" rid="B46">46</xref>). BlueDot (<xref ref-type="bibr" rid="B47">47</xref>) reported COVID-19 outbreaks 10 days before the disease was confirmed by WHO, and has successfully identified urban areas with high risk of spreading the disease (<xref ref-type="bibr" rid="B48">48</xref>).</p>
<p>The Epidemic Intelligence from Open Sources (EIOS<xref ref-type="fn" rid="FN0013"><sup>13</sup></xref>) is an initiative of WHO which integrates existing and new surveillance initiatives, networks, and systems globally (<xref ref-type="bibr" rid="B49">49</xref>). Data is gathered from a range of sources including traditional online media, social media, government and official web sites, blogs, and collaborating initiatives, such as the HealthMap and ProMed-Mail. Using NLP and ML the system sorts and categorizes articles by topics, country, language, source and contextual indices. Data from both EIOS and BlueDot were used to enhance event-based surveillance in Japan during the 2020 Olympic and Paralympic Summer Games, which helped to identify events, characterize risk and reduced the surveillance workload of Japan (<xref ref-type="bibr" rid="B50">50</xref>).</p>
<p>BioCaster<xref ref-type="fn" rid="FN0014"><sup>14</sup></xref> analyzes data from local and international news, sourced from news aggregators such as Google News and RSS feeds. Using NLP and ML the system automatically provides information of disease prevalence and outbreaks specific to a given location, as visual maps and graphs (<xref ref-type="bibr" rid="B51">51</xref>). Similarly, the Medical Information System (MedISys<xref ref-type="fn" rid="FN0015"><sup>15</sup></xref>) monitors events occurring across the globe using information from news articles (<xref ref-type="bibr" rid="B52">52</xref>). The system curates data from official government websites, health news and the general media, and performs categorization of a range of public health threats by applying KB, ML and NLP techniques.</p>
</sec>
</sec>
<sec id="s2" sec-type="discussion"><title>Discussion</title>
<p>These data inputs have several strengths in comparison to traditional methods. A key strength is timeliness as they often rely on automatic data collection. They may also reach to a wider population, more localized areas and population groups, and thus data collected from these systems can be more comprehensive. They can capture important aspects of a disease or transmission, such as changing behavior and perceptions regarding public health policies. These systems also require less human capital to run, and hence are less costly. When all aspects of digital systems are integrated, including data collection, analysis and presentation, this increases flexibility. Despite these benefits, there are notable limitations.</p>
<p>Tools measuring physiological indicators have limited specificity as they often rely on syndromic definitions of diseases, and there is difficulty in adjusting for confounders. Gathering more information in relation to demographics and risk factors to address this may lead to decreased in participation (<xref ref-type="bibr" rid="B53">53</xref>). Some systems using physiological measurements, as well as crowd sourcing, phone data, and mobile apps depend on user generated data. This method of data collection has inherent challenges, including introducing bias as those who choose to participate may not be representative of the general population. Data may also be biased due to user demography. Crowd sourcing can also require a participation over a long period time with recruitment of participants and ongoing engagement challenging.</p>
<p>Similarly, field experiments require a large number of participants making such experiments challenging to implement. This is highlighted by the lengthy disruption in the Safe Blues experiment due to the lockdown started during August 2021 in New Zealand (<xref ref-type="bibr" rid="B36">36</xref>). Furthermore, the results of these studies are restricted to specific populations, and may not be useful for different population groups or locations.</p>
<p>While powerful, mobile phone apps based on contact tracing, QR codes, and GPS based location trackers can create privacy and ethical challenges (<xref ref-type="bibr" rid="B54">54</xref>), and thus can be inefficient due to low user uptake (<xref ref-type="bibr" rid="B55">55</xref>,<xref ref-type="bibr" rid="B56">56</xref>). Privacy and ethical concerns can also arise from social media and web search data, due to the fact that such data are not primarily health related, often include personal characteristics, and owned by private online platforms (<xref ref-type="bibr" rid="B57">57</xref>). Such data can incorrectly predict prevalence due to having irrelevant information in search outputs or changing user behavior (<xref ref-type="bibr" rid="B58">58</xref>).</p>
<p>AI enabled systems collect and interpret data from a broad range of sources in real time and can potentially monitor disease trends and detect emerging diseases. However, this technology requires a large volume of data to make useful insights, and specialist computational infrastructure is needed to manage and store such data. Additionally, many of these data sources are unstructured and contain missing information and errors which again requires specific skills to analyze. As many of the AI enabled system integrate data from social media, they may not be representative of the population, with younger people over-represented in the samples (<xref ref-type="bibr" rid="B59">59</xref>).</p>
<p>In summary, new digital technologies provide benefits and opportunities to improve disease surveillance globally. However, the limitations of these data inputs and associated methods must be understood and addressed when incorporated into public health practice.</p>
</sec>
</body>
<back>
<sec id="s3"><title>Author contributions</title>
<p>All authors contributed to the concept development of this review. AS conducted the initial review and data extraction. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s4" sec-type="funding-information"><title>Funding</title>
<p>Funds for incidentals and research assistance were supplied by the University of Queensland&#x2019;s AI for Pandemics initiative.</p>
</sec>
<sec id="s5" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s6" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<fn-group>
<fn id="FN0001"><p><sup>1</sup><ext-link ext-link-type="uri" xlink:href="https://covid19.who.int">https://covid19.who.int</ext-link></p></fn>
<fn id="FN0002"><p><sup>2</sup><ext-link ext-link-type="uri" xlink:href="www.ncov2019.live">www.ncov2019.live</ext-link></p></fn>
<fn id="FN0003"><p><sup>3</sup><ext-link ext-link-type="uri" xlink:href="www.temptraq.healthcare">www.temptraq.healthcare</ext-link></p></fn>
<fn id="FN0004"><p><sup>4</sup><ext-link ext-link-type="uri" xlink:href="www.corona-datenspende.de/science/en">www.corona-datenspende.de/science/en</ext-link></p></fn>
<fn id="FN0005"><p><sup>5</sup><ext-link ext-link-type="uri" xlink:href="https://detect.scripps.edu">https://detect.scripps.edu</ext-link></p></fn>
<fn id="FN0006"><p><sup>6</sup><ext-link ext-link-type="uri" xlink:href="https://health-study.joinzoe.com/us-2">https://health-study.joinzoe.com/us-2</ext-link></p></fn>
<fn id="FN0007"><p><sup>7</sup><ext-link ext-link-type="uri" xlink:href="www.safeblues.org">www.safeblues.org</ext-link></p></fn>
<fn id="FN0008"><p><sup>8</sup><ext-link ext-link-type="uri" xlink:href="www.fieldlabevenementen.nl/fieldlab-english">www.fieldlabevenementen.nl/fieldlab-english</ext-link></p></fn>
<fn id="FN0009"><p><sup>9</sup><ext-link ext-link-type="uri" xlink:href="www.gphin.canada.ca">www.gphin.canada.ca</ext-link></p></fn>
<fn id="FN0010"><p><sup>10</sup><ext-link ext-link-type="uri" xlink:href="www.healthmap.org">www.healthmap.org</ext-link></p></fn>
<fn id="FN0011"><p><sup>11</sup><ext-link ext-link-type="uri" xlink:href="www.bluedot.global">www.bluedot.global</ext-link></p></fn>
<fn id="FN0012"><p><sup>12</sup><ext-link ext-link-type="uri" xlink:href="www.metabiota.com">www.metabiota.com</ext-link></p></fn>
<fn id="FN0013"><p><sup>13</sup><ext-link ext-link-type="uri" xlink:href="www.who.int/initiatives/eios">www.who.int/initiatives/eios</ext-link></p></fn>
<fn id="FN0014"><p><sup>14</sup><ext-link ext-link-type="uri" xlink:href="www.biocaster.org">www.biocaster.org</ext-link></p></fn>
<fn id="FN0015"><p><sup>15</sup><ext-link ext-link-type="uri" xlink:href="MedISys.newsbrief.eu">MedISys.newsbrief.eu</ext-link></p></fn>
</fn-group>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>RE</given-names></name><name><surname>Mahmud</surname><given-names>AS</given-names></name><name><surname>Miller</surname><given-names>IF</given-names></name><name><surname>Rajeev</surname><given-names>M</given-names></name><name><surname>Fidisoa</surname><given-names>R</given-names></name><name><surname>Rice</surname><given-names>BL</given-names></name></person-group>, et al. <article-title>Infectious disease in an era of global change</article-title>. <source>Nat Rev Microbiol</source>. (<year>2022</year>) <volume>20</volume>:<fpage>193</fpage>&#x2013;<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1038/s41579-021-00639-z</pub-id><pub-id pub-id-type="pmid">34646006</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>E</given-names></name><name><surname>Du</surname><given-names>H</given-names></name><name><surname>Gardner</surname><given-names>L</given-names></name></person-group>. <article-title>An interactive web-based dashboard to track COVID-19 in real time</article-title>. <source>Lancet</source>. (<year>2020</year>) <volume>20</volume>:<fpage>553</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(20)30120-1</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Normile</surname><given-names>D</given-names></name></person-group>. <article-title>Airport screening is largely futile, research shows</article-title>. <source>Science</source>. (<year>2020</year>) <volume>367</volume>:<fpage>1177</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1126/science.367.6483.1177</pub-id><pub-id pub-id-type="pmid">32165563</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>AC</given-names></name><name><surname>Singh</surname><given-names>I</given-names></name><name><surname>Koehler</surname><given-names>E</given-names></name><name><surname>Polgreen</surname><given-names>PM</given-names></name></person-group>. <article-title>A smartphone-driven thermometer application for real-time population-and individual-level influenza surveillance</article-title>. <source>Clin Infect Dis</source>. (<year>2018</year>) <volume>67</volume>:<fpage>388</fpage>&#x2013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1093/cid/ciy073</pub-id><pub-id pub-id-type="pmid">29432526</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Chamberlain</surname><given-names>SD</given-names></name><name><surname>Singh</surname><given-names>I</given-names></name><name><surname>Ariza</surname><given-names>CA</given-names></name><name><surname>Daitch</surname><given-names>AL</given-names></name><name><surname>Philips</surname><given-names>PB</given-names></name><name><surname>Dalziel</surname><given-names>BD</given-names></name></person-group>. <comment>Real-time detection of COVID-19 epicenters within the United States using a network of smart thermometers. <italic>MedRxiv</italic> (2020). Available from: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/2020.04.06.20039909">https://doi.org/10.1101/2020.04.06.20039909</ext-link></comment></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seshadri</surname><given-names>DR</given-names></name><name><surname>Davies</surname><given-names>EV</given-names></name><name><surname>Harlow</surname><given-names>ER</given-names></name><name><surname>Hsu</surname><given-names>JJ</given-names></name><name><surname>Knighton</surname><given-names>SC</given-names></name><name><surname>Walker</surname><given-names>TA</given-names></name></person-group>, et al. <article-title>Wearable sensors for COVID-19: a call to action to harness our digital infrastructure for remote patient monitoring, virtual assessments</article-title>. <source>Front Digit Health</source>. (<year>2020</year>) <volume>2</volume>:<fpage>8</fpage>. <pub-id pub-id-type="doi">10.3389/fdgth.2020.00008</pub-id><pub-id pub-id-type="pmid">34713021</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Metwally</surname><given-names>AA</given-names></name><name><surname>Bogu</surname><given-names>GK</given-names></name><name><surname>Brooks</surname><given-names>AW</given-names></name><name><surname>Bahmani</surname><given-names>A</given-names></name></person-group>, et al. <article-title>Pre-symptomatic detection of COVID-19 from smartwatch data</article-title>. <source>Nat Biomed Eng</source>. (<year>2020</year>) <volume>4</volume>:<fpage>1208</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1038/s41551-020-00640-6</pub-id><pub-id pub-id-type="pmid">33208926</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>DJ</given-names></name><name><surname>Capodilupo</surname><given-names>JV</given-names></name><name><surname>Lastella</surname><given-names>M</given-names></name><name><surname>Sargent</surname><given-names>C</given-names></name><name><surname>Roach</surname><given-names>GD</given-names></name><name><surname>Lee</surname><given-names>VH</given-names></name></person-group>, et al. <article-title>Analyzing changes in respiratory rate to predict the risk of COVID-19 infection</article-title>. <source>PLoS ONE</source>. (<year>2020</year>) <volume>15</volume>:<fpage>e0243693</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0243693</pub-id><pub-id pub-id-type="pmid">33301493</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clingan</surname><given-names>CA</given-names></name><name><surname>Dittakavi</surname><given-names>M</given-names></name><name><surname>Rozwadowski</surname><given-names>M</given-names></name><name><surname>Gilley</surname><given-names>KN</given-names></name><name><surname>Cislo</surname><given-names>CR</given-names></name><name><surname>Barabas</surname><given-names>J</given-names></name></person-group>, et al. <article-title>Monitoring health care workers at risk for COVID-19 using wearable sensors, smartphone technology: Protocol for an observational mHealth study</article-title>. <source>JMIR Res Protoc</source>. (<year>2021</year>) <volume>10</volume>:<fpage>e29562</fpage>. <pub-id pub-id-type="doi">10.2196/29562</pub-id><pub-id pub-id-type="pmid">33945497</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Purawat</surname><given-names>S</given-names></name><name><surname>Dasgupta</surname><given-names>S</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Davis</surname><given-names>S</given-names></name><name><surname>Claypool</surname><given-names>KT</given-names></name><name><surname>Chandra</surname><given-names>S</given-names></name></person-group>, et al. <comment>TemPredict: a big data analytical platform for scalable exploration and monitoring of personalized multimodal data for COVID-19. <italic>2021 IEEE International Conference on Big Data (Big Data)</italic>. IEEE (2021). p. 4411&#x2013;4420. Available from: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1109/BigData52589.2021.9671441">https://doi.org/10.1109/BigData52589.2021.9671441</ext-link></comment>.</citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smarr</surname><given-names>BL</given-names></name><name><surname>Aschbacher</surname><given-names>K</given-names></name><name><surname>Fisher</surname><given-names>SM</given-names></name><name><surname>Chowdhary</surname><given-names>A</given-names></name><name><surname>Dilchert</surname><given-names>S</given-names></name><name><surname>Puldon</surname><given-names>K</given-names></name></person-group>, et al. <article-title>Feasibility of continuous fever monitoring using wearable devices</article-title>. <source>Sci Rep</source>. (<year>2020</year>) <volume>10</volume>:<fpage>1</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-78355-6</pub-id><pub-id pub-id-type="pmid">31913322</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mason</surname><given-names>AE</given-names></name><name><surname>Hecht</surname><given-names>FM</given-names></name><name><surname>Davis</surname><given-names>SK</given-names></name><name><surname>Natale</surname><given-names>JL</given-names></name><name><surname>Hartogensis</surname><given-names>W</given-names></name><name><surname>Damaso</surname><given-names>N</given-names></name></person-group>, et al. <article-title>Detection of COVID-19 using multimodal data from a wearable device: results from the first TemPredict Study</article-title>. <source>Sci Rep</source>. (<year>2022</year>) <volume>12</volume>:<fpage>1</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-022-07314-0</pub-id><pub-id pub-id-type="pmid">34992227</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mason</surname><given-names>AE</given-names></name><name><surname>Kasl</surname><given-names>P</given-names></name><name><surname>Hartogensis</surname><given-names>W</given-names></name><name><surname>Natale</surname><given-names>JL</given-names></name><name><surname>Dilchert</surname><given-names>S</given-names></name><name><surname>Dasgupta</surname><given-names>S</given-names></name></person-group>, et al. <article-title>Metrics from wearable devices as candidate predictors of antibody response following vaccination against COVID-19: data from the second tempredict study</article-title>. <source>Vaccines</source>. (<year>2022</year>) <volume>10</volume>:<fpage>264</fpage>. <pub-id pub-id-type="doi">10.3390/vaccines10020264</pub-id><pub-id pub-id-type="pmid">35214723</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Wiedermann</surname><given-names>M</given-names></name><name><surname>Rose</surname><given-names>AH</given-names></name><name><surname>Maier</surname><given-names>BF</given-names></name><name><surname>Kolb</surname><given-names>JJ</given-names></name><name><surname>Hinrichs</surname><given-names>D</given-names></name><name><surname>Brockmann</surname><given-names>D</given-names></name></person-group>. <comment>Evidence for positive long- and short-term effects of vaccinations against COVID-19 in wearable sensor metrics&#x2013;Insights from the German Corona Data Donation Project [preprint] (2022). Available at: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.48550/arXiv.2204.02846">https://doi.org/10.48550/arXiv.2204.02846</ext-link></comment></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quer</surname><given-names>G</given-names></name><name><surname>Radin</surname><given-names>JM</given-names></name><name><surname>Gadaleta</surname><given-names>M</given-names></name><name><surname>Baca-Motes</surname><given-names>K</given-names></name><name><surname>Ariniello</surname><given-names>L</given-names></name><name><surname>Ramos</surname><given-names>E</given-names></name></person-group>, et al. <article-title>Wearable sensor data and self&#x2013;reported symptoms for COVID-19 detection</article-title>. <source>Nat Med</source>. (<year>2021</year>) <volume>27</volume>:<fpage>73</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/s41591-020-1123-x</pub-id><pub-id pub-id-type="pmid">33122860</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koppeschaar</surname><given-names>CE</given-names></name><name><surname>Colizza</surname><given-names>V</given-names></name><name><surname>Guerrisi</surname><given-names>C</given-names></name><name><surname>Turbelin</surname><given-names>C</given-names></name><name><surname>Duggan</surname><given-names>J</given-names></name><name><surname>Edmunds</surname><given-names>WJ</given-names></name></person-group>, et al. <article-title>Influenzanet: citizens among 10 countries collaborating to monitor influenza in Europe</article-title>. <source>JMIR Public Health Surveill</source>. (<year>2017</year>) <volume>3</volume>:<fpage>e7429</fpage>. <pub-id pub-id-type="doi">10.2196/publichealth.7429</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chunara</surname><given-names>R</given-names></name><name><surname>Aman</surname><given-names>S</given-names></name><name><surname>Smolinski</surname><given-names>M</given-names></name><name><surname>Brownstein</surname><given-names>JS</given-names></name></person-group>. <article-title>Flu near you: an online self-reported influenza surveillance system in the USA</article-title>. <source>Online J Public Health Inform</source>. (<year>2013</year>) <volume>5</volume>:<fpage>e133</fpage>. <pub-id pub-id-type="doi">10.5210/ojphi.v5i1.4456</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Noort</surname><given-names>SP</given-names></name><name><surname>Muehlen</surname><given-names>M</given-names></name><name><surname>De Andrade</surname><given-names>HR</given-names></name><name><surname>Koppeschaar</surname><given-names>C</given-names></name><name><surname>Louren&#x00E7;o</surname><given-names>JL</given-names></name><name><surname>Gomes</surname><given-names>MG</given-names></name></person-group>. <article-title>Gripenet: an internet-based system to monitor influenza-like illness uniformly across Europe</article-title>. <source>Eurosurveillance</source>. (<year>2007</year>) <volume>12</volume>:<fpage>5</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.2807/esm.12.07.00722-en</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>W&#x00F3;jcik</surname><given-names>OP</given-names></name><name><surname>Brownstein</surname><given-names>JS</given-names></name><name><surname>Chunara</surname><given-names>R</given-names></name><name><surname>Johansson</surname><given-names>MA</given-names></name></person-group>. <article-title>Public health for the people: participatory infectious disease surveillance in the digital age</article-title>. <source>Emerg Themes Epidemiol</source>. (<year>2014</year>) <volume>11</volume>:<fpage>1</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1186/1742-7622-11-7</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mccoll</surname><given-names>K</given-names></name><name><surname>Debin</surname><given-names>M</given-names></name><name><surname>Souty</surname><given-names>C</given-names></name><name><surname>Guerrisi</surname><given-names>C</given-names></name><name><surname>Turbelin</surname><given-names>C</given-names></name><name><surname>Falchi</surname><given-names>A</given-names></name></person-group>, et al. <article-title>Are people optimistically biased about the risk of COVID-19 infection? Lessons from the first wave of the pandemic in Europe</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2021</year>) <volume>19</volume>:<fpage>436</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph19010436</pub-id><pub-id pub-id-type="pmid">35010707</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>SG</given-names></name><name><surname>Carlson</surname><given-names>S</given-names></name><name><surname>Cheng</surname><given-names>AC</given-names></name><name><surname>Chilver</surname><given-names>MB</given-names></name><name><surname>Dwyer</surname><given-names>DE</given-names></name><name><surname>Irwin</surname><given-names>M</given-names></name></person-group>, et al. <article-title>Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza, other respiratory viruses, Australia, March to September 2020</article-title>. <source>Eurosurveillance</source>. (<year>2020</year>) <volume>25</volume>:<fpage>2001847</fpage>. <pub-id pub-id-type="doi">10.2807/1560-7917.ES.2020.25.47.2001847</pub-id><pub-id pub-id-type="pmid">33243355</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baquero</surname><given-names>C</given-names></name><name><surname>Casari</surname><given-names>P</given-names></name><name><surname>Fernandez Anta</surname><given-names>A</given-names></name><name><surname>Garc&#x00ED;a-Garc&#x00ED;a</surname><given-names>A</given-names></name><name><surname>Frey</surname><given-names>D</given-names></name><name><surname>Garcia-Agundez</surname><given-names>A</given-names></name></person-group>, et al. <article-title>The CoronaSurveys system for COVID-19 incidence data collection and processing</article-title>. <source>Front Comput Sci</source>. (<year>2021</year>) <volume>3</volume>:<fpage>641237</fpage>. <pub-id pub-id-type="doi">10.3389/fcomp.2021.641237</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Astley</surname><given-names>CM</given-names></name><name><surname>Tuli</surname><given-names>G</given-names></name><name><surname>Mc Cord-De Iaco</surname><given-names>KA</given-names></name><name><surname>Cohn</surname><given-names>EL</given-names></name><name><surname>Rader</surname><given-names>B</given-names></name><name><surname>Chiu</surname><given-names>S</given-names></name></person-group>, et al. <comment>Global Monitoring of the Impact of COVID-19 Pandemic through Online Surveys Sampled from the Facebook User Base. medRxiv [Preprint] (2021). Available at: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/2021.07.05.21259989">https://doi.org/10.1101/2021.07.05.21259989</ext-link></comment>.</citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alwashmi</surname><given-names>MF</given-names></name></person-group>. <article-title>The use of digital health in the detection and management of COVID-19</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2020</year>) <volume>17</volume>:<fpage>2906</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph17082906</pub-id><pub-id pub-id-type="pmid">32340107</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Menni</surname><given-names>C</given-names></name><name><surname>Valdes</surname><given-names>AM</given-names></name><name><surname>Freidin</surname><given-names>MB</given-names></name><name><surname>Sudre</surname><given-names>CH</given-names></name><name><surname>Nguyen</surname><given-names>LH</given-names></name><name><surname>Drew</surname><given-names>DA</given-names></name></person-group>, et al. <article-title>Real-time tracking of self-reported symptoms to predict potential COVID-19</article-title>. <source>Nat Med</source>. (<year>2020</year>) <volume>26</volume>:<fpage>1037</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1038/s41591-020-0916-2</pub-id><pub-id pub-id-type="pmid">32393804</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sudre</surname><given-names>CH</given-names></name><name><surname>Murray</surname><given-names>B</given-names></name><name><surname>Varsavsky</surname><given-names>T</given-names></name><name><surname>Graham</surname><given-names>MS</given-names></name><name><surname>Penfold</surname><given-names>RS</given-names></name><name><surname>Bowyer</surname><given-names>RC</given-names></name></person-group>, et al. <article-title>Attributes and predictors of long COVID</article-title>. <source>Nat Med</source>. (<year>2021</year>) <volume>27</volume>:<fpage>626</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1038/s41591-021-01292-y</pub-id><pub-id pub-id-type="pmid">33692530</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jarvis</surname><given-names>CI</given-names></name><name><surname>Van Zandvoort</surname><given-names>K</given-names></name><name><surname>Gimma</surname><given-names>A</given-names></name><name><surname>Prem</surname><given-names>K</given-names></name><name><surname>Klepac</surname><given-names>P</given-names></name><name><surname>Rubin</surname><given-names>GJ</given-names></name></person-group>, et al. <article-title>Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK</article-title>. <source>BMC Med</source>. (<year>2020</year>) <volume>18</volume>:<fpage>1</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1186/s12916-020-01597-8</pub-id><pub-id pub-id-type="pmid">31898501</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name></person-group>. <article-title>Using information technology to manage the COVID-19 pandemic: development of a technical framework based on practical experience in China</article-title>. <source>JMIR Med Inform</source>. (<year>2020</year>) <volume>8</volume>:<fpage>e19515</fpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2020.07.024</pub-id><pub-id pub-id-type="pmid">32479411</pub-id></citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wymant</surname><given-names>C</given-names></name><name><surname>Ferretti</surname><given-names>L</given-names></name><name><surname>Tsallis</surname><given-names>D</given-names></name><name><surname>Charalambides</surname><given-names>M</given-names></name><name><surname>Abeler-D&#x00F6;rner</surname><given-names>L</given-names></name><name><surname>Bonsall</surname><given-names>D</given-names></name></person-group>, et al. <article-title>The epidemiological impact of the NHS COVID-19 App</article-title>. <source>Nature</source>. (<year>2021</year>) <volume>594</volume>:<fpage>408</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03606-z</pub-id><pub-id pub-id-type="pmid">33979832</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="other"><collab>[Dataset] Queensland Government</collab>. <comment>Check in Qld app data! (2021). Available from: <ext-link ext-link-type="uri" xlink:href="https://www.data.qld.gov.au/article/news-and-events/check-in-qld-app-data">https://www.data.qld.gov.au/article/news-and-events/check-in-qld-app-data</ext-link> [Accessed November 30, 2022]</comment></citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lwin</surname><given-names>MO</given-names></name><name><surname>Jayasundar</surname><given-names>K</given-names></name><name><surname>Sheldenkar</surname><given-names>A</given-names></name><name><surname>Wijayamuni</surname><given-names>R</given-names></name><name><surname>Wimalaratne</surname><given-names>P</given-names></name><name><surname>Ernst</surname><given-names>KC</given-names></name></person-group>, et al. <article-title>Lessons from the implementation of Mo-Buzz, a mobile pandemic surveillance system for dengue</article-title>. <source>JMIR Public Health Surveill</source>. (<year>2017</year>) <volume>3</volume>:<fpage>e7376</fpage>. <pub-id pub-id-type="doi">10.2196/publichealth.7376</pub-id></citation></ref>
<ref id="B32"><label>32.</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>M</given-names></name><name><surname>Wojcik</surname><given-names>O</given-names></name><name><surname>Chunara</surname><given-names>R</given-names></name><name><surname>Smolinski</surname><given-names>M</given-names></name><name><surname>Brownstein</surname><given-names>J</given-names></name></person-group>. <comment>Participatory disease surveillance in Latin America. <italic>Proceedings of the 22nd International Conference on World Wide Web</italic>. New York: Association for Computing Machinery (2013). p. 695&#x2013;696. Available from: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1145/2487788.2488025">https://doi.org/10.1145/2487788.2488025</ext-link></comment>.</citation></ref>
<ref id="B33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoneki</surname><given-names>E</given-names></name><name><surname>Crowcroft</surname><given-names>J</given-names></name></person-group>. <article-title>EpiMap: towards quantifying contact networks for understanding epidemiology in developing countries</article-title>. <source>Ad Hoc Netw</source>. (<year>2014</year>) <volume>13</volume>:<fpage>83</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.adhoc.2012.06.003</pub-id></citation></ref>
<ref id="B34"><label>34.</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Yoneki</surname><given-names>E</given-names></name></person-group>. <comment>Fluphone study: virtual disease spread using haggle. <italic>Proceedings of the 6th ACM Workshop on Challenged Networks</italic>. New York: Association for Computing Machinery (2011). p. 65&#x2013;66. Available from: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1145/2030652.2030672">https://doi.org/10.1145/2030652.2030672</ext-link></comment>.</citation></ref>
<ref id="B35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dandekar</surname><given-names>R</given-names></name><name><surname>Henderson</surname><given-names>SG</given-names></name><name><surname>Jansen</surname><given-names>HM</given-names></name><name><surname>McDonald</surname><given-names>J</given-names></name><name><surname>Moka</surname><given-names>S</given-names></name><name><surname>Nazarathy</surname><given-names>Y</given-names></name></person-group>, et al. <article-title>Safe Blues: the case for virtual safe virus spread in the long&#x2013;term fight against epidemics</article-title>. <source>Patterns</source>. (<year>2021</year>) <volume>2</volume>:<fpage>100220</fpage>. <pub-id pub-id-type="doi">10.1016/j.patter.2021.100220</pub-id><pub-id pub-id-type="pmid">33748797</pub-id></citation></ref>
<ref id="B36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Asanjarani</surname><given-names>A</given-names></name><name><surname>Shausan</surname><given-names>A</given-names></name><name><surname>Chew</surname><given-names>K</given-names></name><name><surname>Graham</surname><given-names>T</given-names></name><name><surname>Henderson</surname><given-names>SG</given-names></name><name><surname>Jansen</surname><given-names>HM</given-names></name></person-group>, et al. <article-title>Emulation of epidemics via Bluetooth-based virtual safe virus spread: experimental setup, software, and data</article-title>. <source>PLOS Digit Health</source>. (<year>2022</year>) <volume>1</volume>:<fpage>e0000142</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pdig.0000142</pub-id><pub-id pub-id-type="pmid">36812628</pub-id></citation></ref>
<ref id="B37"><label>37.</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Kissler</surname><given-names>SM</given-names></name><name><surname>Klepac</surname><given-names>P</given-names></name><name><surname>Tang</surname><given-names>M</given-names></name><name><surname>Conlan</surname><given-names>AJ</given-names></name><name><surname>Gog</surname><given-names>JR</given-names></name></person-group>. <comment>Sparking &#x201C;The BBC Four Pandemic&#x201D;: leveraging citizen science and mobile phones to model the spread of disease. BioRxiv [Priprint] (2020). p. 479154. Available at: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/479154">https://doi.org/10.1101/479154</ext-link></comment>.</citation></ref>
<ref id="B38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klepac</surname><given-names>P</given-names></name><name><surname>Kissler</surname><given-names>S</given-names></name><name><surname>Gog</surname><given-names>J</given-names></name></person-group>. <article-title>Contagion! the BBC four pandemic&#x2013;the model behind the documentary</article-title>. <source>Epidemics</source>. (<year>2018</year>) <volume>24</volume>:<fpage>49</fpage>&#x2013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.epidem.2018.03.003</pub-id><pub-id pub-id-type="pmid">29576516</pub-id></citation></ref>
<ref id="B39"><label>39.</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Firth</surname><given-names>JA</given-names></name><name><surname>Hellewell</surname><given-names>J</given-names></name><name><surname>Klepac</surname><given-names>P</given-names></name><name><surname>Kissler</surname><given-names>SM</given-names></name><name><surname>Kucharski</surname><given-names>AJ</given-names></name><name><surname>Spurgin</surname><given-names>LG</given-names></name></person-group>, et al. <comment>Combining fine-scale social contact data with epidemic modelling reveals interactions between contact tracing, quarantine, testing and physical distancing for controlling COVID-19. MedRxiv [Priprint] (2020). Available at: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/2020.05.26.20113720">https://doi.org/10.1101/2020.05.26.20113720</ext-link></comment>.</citation></ref>
<ref id="B40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moritz</surname><given-names>S</given-names></name><name><surname>Gottschick</surname><given-names>C</given-names></name><name><surname>Horn</surname><given-names>J</given-names></name><name><surname>Popp</surname><given-names>M</given-names></name><name><surname>Langer</surname><given-names>S</given-names></name><name><surname>Klee</surname><given-names>B</given-names></name></person-group>, et al. <article-title>The risk of indoor sports and culture events for the transmission of COVID-19</article-title>. <source>Nat Commun</source>. (<year>2021</year>) <volume>12</volume>:<fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/s41467-021-25317-9</pub-id><pub-id pub-id-type="pmid">33397941</pub-id></citation></ref>
<ref id="B41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Kim</surname><given-names>EO</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Jung</surname><given-names>J</given-names></name></person-group>. <article-title>Universal Screening of Severe Acute Respiratory Syndrome Coronavirus 2 with Polymerase Chain Reaction Testing after Rally of Trainee Doctors</article-title>. <source>J Korean Med Sci</source>. (<year>2020</year>) <volume>35</volume>:<fpage>e380</fpage>. <pub-id pub-id-type="doi">10.3346/jkms.2020.35.e380</pub-id><pub-id pub-id-type="pmid">33140592</pub-id></citation></ref>
<ref id="B42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Revollo</surname><given-names>B</given-names></name><name><surname>Blanco</surname><given-names>I</given-names></name><name><surname>Soler</surname><given-names>P</given-names></name><name><surname>Toro</surname><given-names>J</given-names></name><name><surname>Izquierdo-Useros</surname><given-names>N</given-names></name><name><surname>Puig</surname><given-names>J</given-names></name></person-group>, et al. <article-title>Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial</article-title>. <source>Lancet Infect Dis</source> (<year>2021</year>) <volume>21</volume>:<fpage>1365</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(21)00268-1</pub-id><pub-id pub-id-type="pmid">34051886</pub-id></citation></ref>
<ref id="B43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ridenhour</surname><given-names>B</given-names></name><name><surname>Kowalik</surname><given-names>JM</given-names></name><name><surname>Shay</surname><given-names>DK</given-names></name></person-group>. <article-title>Unraveling <inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IM3"><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula>: Considerations for public health applications</article-title>. <source>Am J Public Health</source>. (<year>2014</year>) <volume>104</volume>:<fpage>e32</fpage>&#x2013;<lpage>e41</lpage>. <pub-id pub-id-type="doi">10.2105/AJPH.2013.301704</pub-id><pub-id pub-id-type="pmid">24328646</pub-id></citation></ref>
<ref id="B44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dion</surname><given-names>M</given-names></name><name><surname>AbdelMalik</surname><given-names>P</given-names></name><name><surname>Mawudeku</surname><given-names>A</given-names></name></person-group>. <article-title>Big data: big data and the global public health intelligence network (GPHIN)</article-title>. <source>Can Commun Dis Rep</source>. (<year>2015</year>) <volume>41</volume>:<fpage>209</fpage>. <pub-id pub-id-type="doi">10.14745/ccdr.v41i09a02</pub-id><pub-id pub-id-type="pmid">29769954</pub-id></citation></ref>
<ref id="B45"><label>45.</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>D</given-names></name><name><surname>Stojanovic</surname><given-names>M</given-names></name><name><surname>Hachey</surname><given-names>P</given-names></name><name><surname>Fournier</surname><given-names>K</given-names></name><name><surname>Rodier</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group>. <comment>Redesigning GPHIN [Preprint] (2020). Available at: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.48550/arXiv.2004.04596">https://doi.org/10.48550/arXiv.2004.04596</ext-link></comment>.</citation></ref>
<ref id="B46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freifeld</surname><given-names>CC</given-names></name><name><surname>Mandl</surname><given-names>KD</given-names></name><name><surname>Reis</surname><given-names>BY</given-names></name><name><surname>Brownstein</surname><given-names>JS</given-names></name></person-group>. <article-title>HealthMap: global infectious disease monitoring through automated classification and visualization of Internet media reports</article-title>. <source>J Am Med Inform Assoc</source>. (<year>2008</year>) <volume>15</volume>:<fpage>150</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1197/jamia.M2544</pub-id><pub-id pub-id-type="pmid">18096908</pub-id></citation></ref>
<ref id="B47"><label>47.</label><citation citation-type="other"><collab>[Dataset] BlueDot</collab>. <comment>BlueDot products: AI-driven infectious disease surveillance (2013). Available from: <ext-link ext-link-type="uri" xlink:href="https://bluedot.global">https://bluedot.global</ext-link></comment>.</citation></ref>
<ref id="B48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bogoch</surname><given-names>II</given-names></name><name><surname>Watts</surname><given-names>A</given-names></name><name><surname>Thomas-Bachli</surname><given-names>A</given-names></name><name><surname>Huber</surname><given-names>C</given-names></name><name><surname>Kraemer</surname><given-names>MU</given-names></name><name><surname>Khan</surname><given-names>K</given-names></name></person-group>. <article-title>Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel</article-title>. <source>J Travel Med</source>. (<year>2020</year>) <volume>27</volume>:<fpage>taaa008</fpage>. <pub-id pub-id-type="doi">10.1093/jtm/taaa008</pub-id><pub-id pub-id-type="pmid">31943059</pub-id></citation></ref>
<ref id="B49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>O</given-names></name><name><surname>Pebody</surname><given-names>R</given-names></name></person-group>. <article-title>The WHO hub for pandemic and epidemic intelligence: supporting better preparedness for future health emergencies</article-title>. <source>Eurosurveillance</source>. (<year>2022</year>) <volume>27</volume>:<fpage>2200385</fpage>. <pub-id pub-id-type="doi">10.2807/1560-7917.ES.2022.27.20.2200385</pub-id><pub-id pub-id-type="pmid">35593162</pub-id></citation></ref>
<ref id="B50"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kasamatsu</surname><given-names>A</given-names></name><name><surname>Ota</surname><given-names>M</given-names></name><name><surname>Shimada</surname><given-names>T</given-names></name><name><surname>Fukusumi</surname><given-names>M</given-names></name><name><surname>Yamagishi</surname><given-names>T</given-names></name><name><surname>Samuel</surname><given-names>A</given-names></name></person-group>, et al. <article-title>Enhanced event-based surveillance for imported diseases during the Tokyo 2020 Olympic and Paralympic Games</article-title>. <source>Western Pacific Surveillance and Response Journal: WPSAR</source>. (<year>2021</year>) <volume>12</volume>:<fpage>1</fpage>. <pub-id pub-id-type="doi">10.5365/wpsar.2021.12.4.903</pub-id><pub-id pub-id-type="pmid">35251745</pub-id></citation></ref>
<ref id="B51"><label>51.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>Z</given-names></name><name><surname>Okhmatovskaia</surname><given-names>A</given-names></name><name><surname>Polleri</surname><given-names>M</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Powell</surname><given-names>G</given-names></name><name><surname>Fu</surname><given-names>Z</given-names></name></person-group>, et al. <article-title>BioCaster in 2021: automatic disease outbreaks detection from global news media</article-title>. <source>Bioinformatics</source>. (<year>2022</year>) <volume>38</volume>:<fpage>4446</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btac497</pub-id><pub-id pub-id-type="pmid">35900173</pub-id></citation></ref>
<ref id="B52"><label>52.</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Linge</surname><given-names>JP</given-names></name><name><surname>Steinberger</surname><given-names>R</given-names></name><name><surname>Fuart</surname><given-names>F</given-names></name><name><surname>Bucci</surname><given-names>S</given-names></name><name><surname>Belyaeva</surname><given-names>J</given-names></name><name><surname>Gemo</surname><given-names>M</given-names></name></person-group>, et al. <comment>MedISys: medical information system. <italic>Advanced ICTs for disaster management and threat detection: collaborative and distributed frameworks</italic>. IGI Global (2010). p. 131&#x2013;142. Available from: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4018/978-1-61520-987-3.ch009">https://doi.org/10.4018/978-1-61520-987-3.ch009</ext-link></comment>.</citation></ref>
<ref id="B53"><label>53.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trifan</surname><given-names>A</given-names></name><name><surname>Oliveira</surname><given-names>M</given-names></name><name><surname>Oliveira</surname><given-names>JL</given-names></name></person-group>. <article-title>Passive sensing of health outcomes through smartphones: systematic review of current solutions and possible limitations</article-title>. <source>JMIR Mhealth Uhealth</source>. (<year>2019</year>) <volume>7</volume>:<fpage>e12649</fpage>. <pub-id pub-id-type="doi">10.2196/12649</pub-id><pub-id pub-id-type="pmid">31444874</pub-id></citation></ref>
<ref id="B54"><label>54.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kleinman</surname><given-names>RA</given-names></name><name><surname>Merkel</surname><given-names>C</given-names></name></person-group>. <article-title>Digital contact tracing for COVID-19</article-title>. <source>CMAj</source>. (<year>2020</year>) <volume>192</volume>:<fpage>E653</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1503/cmaj.200922</pub-id><pub-id pub-id-type="pmid">32461324</pub-id></citation></ref>
<ref id="B55"><label>55.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vogt</surname><given-names>F</given-names></name><name><surname>Haire</surname><given-names>B</given-names></name><name><surname>Selvey</surname><given-names>L</given-names></name><name><surname>Katelaris</surname><given-names>AL</given-names></name><name><surname>Kaldor</surname><given-names>J</given-names></name></person-group>. <article-title>Effectiveness evaluation of digital contact tracing for COVID-19 in New South Wales, Australia</article-title>. <source>Lancet Public Health</source>. (<year>2022</year>) <volume>7</volume>:<fpage>e250</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/S2468-2667(22)00010-X</pub-id><pub-id pub-id-type="pmid">35131045</pub-id></citation></ref>
<ref id="B56"><label>56.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Michaleff</surname><given-names>ZA</given-names></name><name><surname>Greenwood</surname><given-names>H</given-names></name><name><surname>Abukmail</surname><given-names>E</given-names></name><name><surname>Glasziou</surname><given-names>P</given-names></name></person-group>. <article-title>Concerns and misconceptions about the Australian government&#x2019;s COVIDsafe app: Cross-sectional survey study</article-title>. <source>JMIR Public Health and Surveillance</source>. (<year>2020</year>) <volume>6</volume>:<fpage>e23081</fpage>. <pub-id pub-id-type="doi">10.2196/23081</pub-id><pub-id pub-id-type="pmid">33048826</pub-id></citation></ref>
<ref id="B57"><label>57.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mittelstadt</surname><given-names>B</given-names></name><name><surname>Benzler</surname><given-names>J</given-names></name><name><surname>Engelmann</surname><given-names>L</given-names></name><name><surname>Prainsack</surname><given-names>B</given-names></name><name><surname>Vayena</surname><given-names>E</given-names></name></person-group>. <article-title>Is there a duty to participate in digital epidemiology?</article-title> <source>Life Sci Soc Policy</source>. (<year>2018</year>) <volume>14</volume>:<fpage>1</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1186/s40504-018-0074-1</pub-id><pub-id pub-id-type="pmid">29302758</pub-id></citation></ref>
<ref id="B58"><label>58.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aiello</surname><given-names>AE</given-names></name><name><surname>Renson</surname><given-names>A</given-names></name><name><surname>Zivich</surname><given-names>P</given-names></name></person-group>. <article-title>Social media-and internet-based disease surveillance for public health</article-title>. <source>Annu Rev Public Health</source>. (<year>2020</year>) <volume>41</volume>:<fpage>101</fpage>. <pub-id pub-id-type="doi">10.1146/annurev-publhealth-040119-094402</pub-id><pub-id pub-id-type="pmid">31905322</pub-id></citation></ref>
<ref id="B59"><label>59.</label><citation citation-type="other"><person-group person-group-type="author"><name><surname>Naud&#x00E9;</surname><given-names>W</given-names></name></person-group>. <comment>Artificial Intelligence against COVID-19: an early review. SSRN [Preprint] (2020). Available at: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2139/ssrn.3568314">http://dx.doi.org/10.2139/ssrn.3568314</ext-link></comment>.</citation></ref></ref-list>
</back>
</article>